GA
About
Board member or advisor for several biotech companies ; co-founder and COO of BioAlliance Pharma SA – ONXEO (NYSE EURONEXT) until 2010. Gilles Avenard was involved in the development of several innovative medicines until their registration in Europe and the USA. Before that, he was Projects Director for Hoechst Marion Roussel (Sanofi) and Medical Director of Bio-Transfusion (LFB).
Position in the VCSift Database
- • 3 investors at Acticor Biotech are tracked.
- • 3,360 investors hold the CEO role in VCSift. Gilles Avenard is one of them.
- • 2,833 investors are based in Paris, Ile-de-France, France.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- Paris, France
Contact Information
linkedin.com/in/••••••••
Find more investors like Gilles
Search Investors